drugset / Trial / NCT04693429
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
NaSingle-groupOpen-labelOther
Summary
Clinical phase I, controlled, non comparative, open, single center study evaluating the safety and tolerability of ophthalmic solution PRO-172 when applied on the ocular surface of healthy volunteers.
Timeline
- Start
- 2020-09-24
- Primary completion
- 2020-11-27
- Completion
- 2020-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bepotastine | Small molecule | 1.5 % | Topical |
Indications
No indication recorded.